Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

2.

The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats.

Allen RM, Dykstra LA.

Psychopharmacology (Berl). 1999 Feb;142(2):209-14.

PMID:
10102774
3.
4.

Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.

Tiseo PJ, Cheng J, Pasternak GW, Inturrisi CE.

J Pharmacol Exp Ther. 1994 Jan;268(1):195-201.

PMID:
8301558
8.

NMDA antagonist modulation of morphine antinociception in female vs. male rats.

Craft RM, Lee DA.

Pharmacol Biochem Behav. 2005 Apr;80(4):639-49.

PMID:
15820534
9.
11.
12.

Inhibition of the N-methyl-d-aspartate receptor unmasks the antinociception of endogenous opioids in the periphery.

Zhang GH, Min SS, Seol GH, Lee KS, Han H, Kim YI, Han HC.

Pain. 2009 Jun;143(3):233-7. doi: 10.1016/j.pain.2009.03.007. Epub 2009 Apr 9.

PMID:
19361925
13.
14.

Effects of short-acting NMDA receptor antagonist MRZ 2/576 on morphine tolerance development in mice.

Belozertseva IV, Danysz W, Bespalov AY.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Jun;361(6):573-7.

PMID:
10882030
16.

Are glycineB sites involved in the development of morphine tolerance?

Kotlińska J.

Pol J Pharmacol. 2004 Jan-Feb;56(1):51-7.

18.

Interaction of memantine and ketamine in morphine- and pentazocine-induced antinociception in mice.

Malec D, Mandryk M, Fidecka S.

Pharmacol Rep. 2008 Mar-Apr;60(2):149-55.

19.
20.

Supplemental Content

Support Center